Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

West China Hospital · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
braf v600e-mutated /mss metastatic colorectal cancer, vemurafenib (brafi) plus cetuximab (egfri) combined with pd-1 monoclonal antibody, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 860182
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.